80 related articles for article (PubMed ID: 1144332)
1. [Treatment of polycythemia with myelosan under ambulatory conditions].
Krasiukova LI
Probl Gematol Pereliv Krovi; 1975 May; 20(5):37-40. PubMed ID: 1144332
[No Abstract] [Full Text] [Related]
2. [Current aspects of the treatment of polycythemia vera under polyclinical conditions].
Osechenskaia GV; Krasiukova LI
Probl Gematol Pereliv Krovi; 1978 Jan; 23(1):21-4. PubMed ID: 628661
[No Abstract] [Full Text] [Related]
3. [The vascular manifestations of polycythemia].
Viala JJ; Brun F; Chataing B
Lyon Med; 1968 Jun; 219(23):1907-12 passim. PubMed ID: 5670634
[No Abstract] [Full Text] [Related]
4. [Therapeutic effect of busulfan in polycythemia].
Popović K; Stanulovic D
Med Pregl; 1971; 24(9):479-81. PubMed ID: 5156502
[No Abstract] [Full Text] [Related]
5. [The treatment of polycythemia vera with busulfan].
Kratochvil J; Mrkos D
Vnitr Lek; 1966 Jul; 12(7):673-81. PubMed ID: 5967585
[No Abstract] [Full Text] [Related]
6. Two cases of primary erythremia treated with Busulfan.
Zawada W
Mater Med Pol; 1974; 6(2):140-2. PubMed ID: 4431247
[No Abstract] [Full Text] [Related]
7. Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera.
Penttilä O; Ikkala E
Ann Med Intern Fenn; 1968; 57(2):99-101. PubMed ID: 5706392
[No Abstract] [Full Text] [Related]
8. [Results of long-term therapy of essential polycythemia using myleran. Definition of criteria for an adequate posology].
Maurice PA; Alberto P
Schweiz Med Wochenschr; 1967 Nov; 97(44):1477-8. PubMed ID: 5593694
[No Abstract] [Full Text] [Related]
9. [Myleran treatment in polycythemia vera].
Yde H
Nord Med; 1971 Aug; 85(32):968. PubMed ID: 5568439
[No Abstract] [Full Text] [Related]
10. [Polycythemia vera: therapeutic use of busulfan. Comparison with radioactive phosphorous].
Jamra M; Verrastro T
Rev Hosp Clin Fac Med Sao Paulo; 1967; 22():Suppl:241-66. PubMed ID: 5629089
[No Abstract] [Full Text] [Related]
11. [Case of myelosan-induced hematopoietic aplasia in erythremia].
Demidova AV; Siver AP; Pogorzhel'skiĭ VI
Ter Arkh; 1977; 49(2):133-4. PubMed ID: 860217
[No Abstract] [Full Text] [Related]
12. [Therapy of polycythemia vera with myleran].
Krykowski E; Wislawska B; Polkowska-Kulesza E
Przegl Lek; 1965; 21(7):481-3. PubMed ID: 5848465
[No Abstract] [Full Text] [Related]
13. [Therapy of polycythemia vera with busulfan (myleran). Report on results in 40 patients].
Urasiński I; Mysik M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(4):360-6. PubMed ID: 4101127
[No Abstract] [Full Text] [Related]
14. [Ambulatory treatment of patients with chronic myeloid leukemia].
Lobanova NA
Ter Arkh; 1981; 53(9):25-8. PubMed ID: 6946602
[No Abstract] [Full Text] [Related]
15. [Acute hemopericardium due to acute thrombocytopenia developing during Busulphan treatment of polycythemia vera].
Dyk T; Piotrowski M; Kostecka W
Pol Tyg Lek; 1973 Feb; 28(7):259-60. PubMed ID: 4691200
[No Abstract] [Full Text] [Related]
16. Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors.
Peters WP; Henner WD; Grochow LB; Olsen G; Edwards S; Stanbuck H; Stuart A; Gockerman J; Moore J; Bast RC
Cancer Res; 1987 Dec; 47(23):6402-6. PubMed ID: 2824032
[TBL] [Abstract][Full Text] [Related]
17. Erythropoiesis and erythropoietin in busulphan treated mice.
Barrio Rendo ME; Alvarez Prado de Tombol ; Scaro JL
Acta Physiol Lat Am; 1973; 23(5):327-33. PubMed ID: 4784627
[No Abstract] [Full Text] [Related]
18. [Results of long-term treatment of polycythemia vera with busulfan (Myleran) or dibromomannitol (Myelobromol): analysis of 4 clinical cases observed and treated during more than 7 years].
Alberto P; Maurice PA
Praxis; 1969 Sep; 58(38):1211-6. PubMed ID: 4982355
[No Abstract] [Full Text] [Related]
19. [Vercyte in the therapy of polycythemia].
Fábryová L; Hrubisko M
Vnitr Lek; 1972 Nov; 18(11):1113-6. PubMed ID: 4634660
[No Abstract] [Full Text] [Related]
20. [Chronic myelogenous leukemia. Results of therapy with busulfan].
Olesen J; Videbaek A
Nord Med; 1969 Oct; 82(41):1284-90. PubMed ID: 5260856
[No Abstract] [Full Text] [Related]
[Next] [New Search]
